On ECHEMI
Home > Drugs > Teyi Pharmaceutical Group Co., Ltd.

Teyi Pharmaceutical Group Co., Ltd.

  • Founded in:

    2002-05-23
  • Country:

    China China
  • Address:

    No. 9, 11, Changxing Road, Taicheng, Taishan City
  • Tax NO.:

    91440700738598678Q
  • Registered Funds:

    510.788782 million yuan
  • Website:

  • Email:

Related Drugs
Glucuronolactone tablets
Glucuronolactone
Name Description Content CAS NO. Registered Holders
D-Glucurone

After entering the body, this product can combine with poisons containing hydroxyl or carboxyl groups to form low-toxic or non-toxic combinations that are excreted in the urine, protecting the liver and detoxifying. In addition, glucuronic acid can increase the content of liver glycogen and reduce fat reserves.

More

After entering the body, this product can combine with poisons containing hydroxyl or carboxyl groups to form low-toxic or non-toxic combinations that are excreted in the urine, protecting the liver and detoxifying. In addition, glucuronic acid can increase the content of liver glycogen and reduce fat reserves.

32449-92-6 6
Glucuronolactone tablets
Glucuronolactone
Name Description Content CAS NO. Registered Holders
D-Glucurone

After entering the body, this product can combine with poisons containing hydroxyl or carboxyl groups to form low-toxic or non-toxic combinations that are excreted in the urine, protecting the liver and detoxifying. In addition, glucuronic acid can increase the content of liver glycogen and reduce fat reserves.

More

After entering the body, this product can combine with poisons containing hydroxyl or carboxyl groups to form low-toxic or non-toxic combinations that are excreted in the urine, protecting the liver and detoxifying. In addition, glucuronic acid can increase the content of liver glycogen and reduce fat reserves.

32449-92-6 6
Compound Chuanbei Essence Tablets
Fritillaria cirrhosa, ephedra, dried orange peel, pinellia tuber, platycodon grandiflorum, polygala tenuifolia, schisandra chinensis, licorice extract. Excipients: sucrose, dextrin, magnesium stearate, talc, gum arabic, gelatin, dimethicone, Sichuan wax.
Name Description Content CAS NO. Registered Holders
Dehydroandrographolide

134418-28-3 0
Ephedra

0
Citri reticulatae pericarpium

0
PinelliaTuber

0
Platycodonis Radix

0
polygala

0
Anise oil

8007-70-3 10
Licorice extract

68916-91-6 0
Compound sulfadiazine tablets
This product is a compound preparation. Each tablet contains the following active ingredients: 0.4g sulfadiazine and 50mg trimethoprim.
Name Description Content CAS NO. Registered Holders
Sulfadiazine

It acts on dihydrofolate synthase, interfering with the first step of folic acid synthesis. When used in combination with trimethoprim, it can double block the folic acid metabolism of bacteria and has a synergistic antibacterial effect.

More

It acts on dihydrofolate synthase, interfering with the first step of folic acid synthesis. When used in combination with trimethoprim, it can double block the folic acid metabolism of bacteria and has a synergistic antibacterial effect.

0.4g 68-35-9 14
Trimethoprim

It acts on the second step of folic acid anabolism, selectively inhibits the action of dihydrofolate reductase, and when used in combination with sulfadiazine, it can double-block the folic acid metabolism of bacteria, thus having a synergistic antibacterial effect.

More

It acts on the second step of folic acid anabolism, selectively inhibits the action of dihydrofolate reductase, and when used in combination with sulfadiazine, it can double-block the folic acid metabolism of bacteria, thus having a synergistic antibacterial effect.

50mg 738-70-5 44
Qumixin Cream
This product is a compound preparation, and its components are 100 mg of miconazole nitrate, 10 mg of triamcinolone acetonide acetate, and 30,000 units of neomycin sulfate per 10 g.
Name Description Content CAS NO. Registered Holders
Miconazole nitrate

This product is a broad-spectrum antifungal drug. It interferes with the activity of cytochrome P450, inhibits the biosynthesis of ergosterol in fungal cell membranes, damages fungal cells and changes their permeability, leading to leakage of intracellular substances. It can also inhibit the biosynthesis of triglycerides and phospholipids in fungi, inhibit the activity of oxidases and peroxidases, cause accumulation of hydrogen peroxide in cells, and lead to cell submicrostructure degeneration and cell necrosis. For Candida albicans, it can inhibit the process of transformation from spores to invasive hyphae.

More

This product is a broad-spectrum antifungal drug. It interferes with the activity of cytochrome P450, inhibits the biosynthesis of ergosterol in fungal cell membranes, damages fungal cells and changes their permeability, leading to leakage of intracellular substances. It can also inhibit the biosynthesis of triglycerides and phospholipids in fungi, inhibit the activity of oxidases and peroxidases, cause accumulation of hydrogen peroxide in cells, and lead to cell submicrostructure degeneration and cell necrosis. For Candida albicans, it can inhibit the process of transformation from spores to invasive hyphae.

100mg 22832-87-7 31
Triamcinolone acetonide 21-acetate

It has the anti-inflammatory, anti-allergic and vasoconstrictive effects of topical glucocorticoids.

More

It has the anti-inflammatory, anti-allergic and vasoconstrictive effects of topical glucocorticoids.

10mg 3870-07-3 5
Neomycin sulfate

It has antibacterial effect on Staphylococcus (methicillin-sensitive strains), Corynebacterium and other bacteria.

More

It has antibacterial effect on Staphylococcus (methicillin-sensitive strains), Corynebacterium and other bacteria.

30,000unit 1405-10-3 11
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.